UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.48B |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$690M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$588M |
| 4 |
Truist Financial
TFC
|
+$532M |
| 5 |
VanEck Gold Miners ETF
GDX
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.3B |
| 2 |
Alibaba
BABA
|
+$771M |
| 3 |
AABA
Altaba Inc
AABA
|
+$759M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$503M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$467M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.31% |
| 2 | Technology | 9.89% |
| 3 | Financials | 7.42% |
| 4 | Healthcare | 6.84% |
| 5 | Consumer Discretionary | 5.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Skywest
SKYW
$3.97B
| $5.44M | ﹤0.01% |
84,123
+50,810
| +153% | +$3.09M |
|
2527
Azenta
AZTA
$1.49B
| $5.43M | ﹤0.01% |
129,412
+46,314
| +56% | +$1.95M |
|
2528
Sensient Technologies
SXT
$5.5B
| $5.43M | ﹤0.01% |
82,113
+40,432
| +97% | +$2.59M |
|
2529
Neogen
NEOG
$3B
| $5.42M | ﹤0.01% |
166,046
+52,590
| +46% | +$1.73M |
|
2530
PUT
iShares MSCI Turkey ETF
TUR
$204M
| $5.42M | ﹤0.01% |
+200,000
| New | +$5.17M |
|
2531
Idacorp
IDA
$7.51B
| $5.42M | ﹤0.01% |
50,718
+22,887
| +82% | +$2.45M |
|
2532
Middleby
MIDD
$4.87B
| $5.41M | ﹤0.01% |
49,437
-6,044
| -11% | -$694K |
|
2533
Nektar Therapeutics
NKTR
$1.95B
| $5.4M | ﹤0.01% |
16,675
+4,585
| +38% | +$1.33M |
|
2534
PUT
Ashland
ASH
$3.16B
| $5.39M | ﹤0.01% |
70,500
| – | – |
|
|
HI
2535
DELISTED
Hillenbrand
HI
| $5.38M | ﹤0.01% |
161,584
+19,421
| +14% | +$613K |
|
2536
CALL
Papa John's
PZZA
$644M
| $5.37M | ﹤0.01% |
+85,100
| New | +$5.04M |
|
2537
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$415M
| $5.37M | ﹤0.01% |
94,125
-4,982
| -5% | -$263K |
|
|
UN
2538
CALL
DELISTED
Unilever NV New York Registry Shares
UN
| $5.37M | ﹤0.01% |
+93,500
| New | +$5.52M |
|
2539
American Homes 4 Rent
AMH
$11B
| $5.36M | ﹤0.01% |
204,657
+135,714
| +197% | +$3.54M |
|
|
LNW
2540
DELISTED
Light & Wonder
LNW
| $5.36M | ﹤0.01% |
200,218
+33,077
| +20% | +$852K |
|
2541
CALL
Occidental Petroleum
OXY
$56.8B
| $5.35M | ﹤0.01% |
129,900
+4,900
| +4% | +$196K |
|
2542
Petrobras Class A
PBR.A
$119B
| $5.35M | ﹤0.01% |
358,512
+104,836
| +41% | +$1.49M |
|
2543
Dana Inc
DAN
$2.92B
| $5.34M | ﹤0.01% |
293,653
+175,125
| +148% | +$2.92M |
|
2544
PIMCO Enhanced Low Duration Active Exchange-Traded Fund
LDUR
$1.34B
| $5.33M | ﹤0.01% |
53,352
-2,511
| -4% | -$251K |
|
|
BKI
2545
DELISTED
Black Knight, Inc. Common Stock
BKI
| $5.32M | ﹤0.01% |
82,466
+30,658
| +59% | +$1.9M |
|
2546
Western Alliance Bancorporation
WAL
$8.47B
| $5.32M | ﹤0.01% |
93,284
-51,210
| -35% | -$2.62M |
|
2547
NewMarket
NEU
$8.26B
| $5.32M | ﹤0.01% |
10,925
+8,072
| +283% | +$3.88M |
|
2548
TD Synnex
SNX
$20.8B
| $5.32M | ﹤0.01% |
82,550
+56,756
| +220% | +$3.42M |
|
2549
iShares MSCI New Zealand ETF
ENZL
$70.4M
| $5.32M | ﹤0.01% |
92,023
-4,429
| -5% | -$240K |
|
2550
J&J Snack Foods
JJSF
$1.45B
| $5.31M | ﹤0.01% |
28,836
-1,585
| -5% | -$298K |
|
Similar funds
UBS Group's Q4 2019 Portfolio in Review
As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q4 2019 filing shows 807 new, 4,306 increased, 2,683 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 50% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
- UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
- UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
- UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
- UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
- UBS Group opened 807 new positions and closed 688 in Q4 2019.
- UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.
Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.